Online citations, reference lists, and bibliographies.
← Back to Search

Caring For Patients With Mesothelioma: Principles And Guidelines

M. Hesdorffer, Gleneara E. Bates-Pappas
Published 2019 ·

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1126/scitranslmed.3008639
Merlin Deficiency Predicts FAK Inhibitor Sensitivity: A Synthetic Lethal Relationship
I. Shapiro (2014)
10.15585/mmwr.mm6608a3
Malignant Mesothelioma Mortality — United States, 1999–2015
J. Mazurek (2017)
10.1016/j.athoracsur.2016.06.069
A Multicenter Study of Volumetric Computed Tomography for Staging Malignant Pleural Mesothelioma.
V. Rusch (2016)
10.1002/cncr.28434
Prevalence and characteristics of moderate to severe fatigue: A multicenter study in cancer patients and survivors
X. Wang (2014)
10.6004/JNCCN.2016.0087
NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016.
D. Ettinger (2016)
10.1097/SPC.0b013e32835391dc
Exercise therapy in the management of dyspnea in patients with cancer
G. Koelwyn (2012)
2017). As patients and families navigate the transition
families Shalev (2017)
10.2217/LMT.14.27
Mouse models of mesothelioma: strengths, limitations and clinical translation
C. Robinson (2014)
10.2214/AJR.11.7015
Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume.
R. Gill (2012)
10.1016/j.tranon.2014.12.002
Changing Pattern in Malignant Mesothelioma Survival
J. Faig (2015)
10.4178/EPIH.E2016039
Occupation and mesothelioma in Sweden: updated incidence in men and women in the 27 years after the asbestos ban
N. Plato (2016)
10.1016/j.ejcts.2010.01.008
Effect of induction chemotherapy on lung function and exercise capacity in patients affected by malignant pleural mesothelioma.
G. Marulli (2010)
10.1016/j.jtho.2015.10.003
Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma
A. Billè (2016)
10.1002/ijc.24711
Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005
N. Le Stang (2010)
10.1002/14651858.CD009419.PUB3
Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease.
S. Jones (2016)
10.3978/j.issn.2072-1439.2014.03.16
The Six-Minute-Walk Test in assessing respiratory function after tumor surgery of the lung: a cohort study.
O. Rick (2014)
10.1007/978-0-387-88441-7_26
[Pleural mesothelioma].
A. DE GASPERIS (1950)
Using the SDM paradigm frequently involves altering the language
ease Durand (2014)
10.5014/AJOT.52.8.666
A review of balance instruments for older adults.
S. Whitney (1998)
10.1186/1756-0500-7-269
Comparison of walking performance over the first 2 minutes and the full 6 minutes of the Six-Minute Walk Test
Richard W. Bohannon (2013)
10.21037/jtd.2017.03.164
Pleural and peritoneal mesotheliomas in the Friuli Venezia Giulia register: data analysis from 1995 to 2015 in Northeastern Italy.
Flavia D'Agostin (2017)
10.1002/cncr.20315
Adapting the Lung Cancer Symptom Scale (LCSS) to mesothelioma
P. Hollen (2004)
10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N
The rapid assessment of fatigue severity in cancer patients
T. Mendoza (1999)
10.1016/j.trsl.2017.04.004
CAR T-cell therapy for lung cancer and malignant pleural mesothelioma.
M. Zeltsman (2017)
10.1172/JCI73340
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors.
A. Marabelle (2013)
Nebulized lidocaine for intractable cough near the end of life.
B. Lingerfelt (2007)
10.1016/S0733-8619(02)00031-2
Neurologic complications of radiation therapy.
N. E. Cross (2003)
More recently, a trial in France randomized patients
Vogelzang (2003)
10.1158/1078-0432.CCR-09-3287
The Design of Phase II Clinical Trials Testing Cancer Therapeutics: Consensus Recommendations from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee
L. Seymour (2010)
10.1016/j.lungcan.2015.05.013
Rehabilitation in patients with radically treated respiratory cancer: A randomised controlled trial comparing two training modalities.
B. Salhi (2015)
10.1371/journal.pone.0145039
Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients
E. Taioli (2015)
10.1016/j.jtho.2017.11.003
National Cancer Database Report on Pneumonectomy Versus Lung-Sparing Surgery for Malignant Pleural Mesothelioma.
Zaid M Abdelsattar (2018)
10.1093/gerona/glu156
Comparative effects of light or heavy resistance power training for improving lower extremity power and physical performance in mobility-limited older adults.
K. Reid (2015)
10.12968/hmed.2017.78.4.219
Palliative care for patients with mesothelioma.
Marianne Tinkler (2017)
10.1002/1097-0142(20010815)92:4+<1049::AID-CNCR1418>3.0.CO;2-H
Palliative care and rehabilitation
J. Santiago-Palma (2001)
10.1007/s00520-016-3228-9
Cancer-related fatigue: appraising evidence-based guidelines for screening, assessment and management
E. Pearson (2016)
10.1007/s11556-012-0118-0
Thirty years of physical activity in oncology in Germany—from the birth of the first rehabilitative cancer sports group until today
K. Schüle (2012)
10.1093/jnci/djt181
Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2.
D. Barton (2013)
10.1002/jcb.20828
Cellular and molecular parameters of mesothelioma
Maria E. Ramos-Nino (2006)
2017). As with lung cancer and other malignancies affecting the chest cavity, opioid
lower dyspnea Puspawati (2017)
10.1186/s12957-017-1233-1
Effects of exercise training on patients with lung cancer who underwent lung resection: a meta-analysis
J. Li (2017)
10.1164/AJRCCM.161.4.16147A
Reference equations for the six-minute walk in healthy adults.
S. Jay (2000)
10.21037/atm.2017.03.41
The impact of surgical approach on quality of life for pleural malignant mesothelioma.
R. Schwartz (2017)
10.1089/jpm.2011.0109
Dyspnea review for the palliative care professional: assessment, burdens, and etiologies.
A. Kamal (2011)
10.1002/cncr.29353
Religion, spirituality, and physical health in cancer patients: A meta‐analysis
H. Jim (2015)
10.1080/2162402X.2018.1494111
Combination immune checkpoint blockade as an effective therapy for mesothelioma
V. Fear (2018)
In this study, 495 patients from 19 countries
Hollen (2004)
10.21037/tlcr.2016.05.05
Approach to offering remote support to mesothelioma patients: the mesothelioma survivor project.
G. Bates (2016)
10.1093/GERONA/58.8.M728
A comparison of leg power and leg strength within the InCHIANTI study: which influences mobility more?
J. Bean (2003)
10.1177/1049909117734845
Examining the Role of Primary Care Physicians and Challenges Faced When Their Patients Transition to Home Hospice Care
A. Shalev (2018)
suggest a dedicated palliative care team with at least a physi
Gaertner (2011)
This study has surpassed the first futility endpoint and continues to recruit
Lim (2017)
10.1093/GERONA/63.10.1076
Functional impact of 10 days of bed rest in healthy older adults.
P. Kortebein (2008)
10.1038/bjc.2014.478
Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales
A. Linton (2014)
10.1002/14651858.CD005623.pub2
Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases.
C. Bausewein (2008)
10.1007/s00421-006-0247-0
Strength, power output and symmetry of leg muscles: effect of age and history of falling
Mark C. Perry (2006)
10.1093/OCCMED/KQI034
Mesothelioma mortality in Great Britain from 1968 to 2001.
D. McElvenny (2005)
10.18632/ONCOTARGET.3487
Targeting the inhibitory receptor CTLA-4 on T cells increased abscopal effects in murine mesothelioma model
Licun Wu (2015)
10.1097/JTO.0000000000000177
B7-H1 Expression in Malignant Pleural Mesothelioma is Associated with Sarcomatoid Histology and Poor Prognosis
A. Mansfield (2014)
10.1097/SPC.0b013e32832b7248
Pulmonary rehabilitation for dyspnea in the palliative-care setting
Sharona Sachs (2009)
10.3389/fonc.2017.00179
Oncolytic Viral Therapy for Mesothelioma
D. Pease (2017)
10.1158/1078-0432.CCR-09-1993
An Overview of the Optimal Planning, Design, and Conduct of Phase I Studies of New Therapeutics
P. LoRusso (2010)
Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors.
A. Nowak (2003)
10.1183/09031936.00000811
Predicting survival in malignant mesothelioma
A. Musk (2011)
10.1200/JCO.2016.67.2675
Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma.
A. Rimner (2016)
This chapter will discuss how occupational therapy can help patients with mesothelioma recover from treatment or adapt to living with the disease
122 popcorn ceilings Becklake (2007)
For patients already prescribed opioids for pain, clinicians
Gamborg (2013)
Many countries have implemented safety measures to reduce occupational
(2005)
Many studies support the strong link between mesothelioma
Corfiati (2014)
10.1016/j.ejca.2010.08.015
MexTAg mice exposed to asbestos develop cancer that faithfully replicates key features of the pathogenesis of human mesothelioma.
C. Robinson (2011)
10.2147/OTT.S113598
Spotlight on bevacizumab and its potential in the treatment of malignant pleural mesothelioma: the evidence to date
Pavel A. Levin (2017)
10.1177/1534735415572887
The Impact of a Multidimensional Exercise Intervention on Physical and Functional Capacity, Anxiety, and Depression in Patients With Advanced-Stage Lung Cancer Undergoing Chemotherapy
M. Quist (2015)
10.1016/S1470-2045(17)30459-X
Radiotherapy for the treatment of malignant pleural mesothelioma.
M. Perrot (2017)
10.1371/journal.pone.0094670
Do Interventions Designed to Support Shared Decision-Making Reduce Health Inequalities? A Systematic Review and Meta-Analysis
M. Durand (2014)
10.1016/S0140-6736(15)01238-6
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial
G. Zalcman (2016)
10.2217/LMT.14.37
Combining chemotherapy and checkpoint blockade in thoracic cancer: how to proceed?
Wayne J. Aston (2014)
10.4049/jimmunol.170.10.4905
Induction of Tumor Cell Apoptosis In Vivo Increases Tumor Antigen Cross-Presentation, Cross-Priming Rather than Cross-Tolerizing Host Tumor-Specific CD8 T Cells1
A. Nowak (2003)
British Lung Foundation. End of life with mesothelioma
ing.html (2017)
attempted to integrate palliative care into medical care
Gaertner (2011)
10.3978/j.issn.2072-1439.2013.11.28
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.
N. van Zandwijk (2013)
10.1001/jamaoncol.2016.1196
Intimacy, Body Image, and Cancer.
G. Bates (2016)
10.1136/bmjresp-2016-000171
Assessment of patient-reported outcome measures in pleural interventions
I. Psallidas (2017)
10.2147/CLEP.S105396
Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)–Medicare investigation of treatment patterns and overall survival
J. Beebe-Dimmer (2016)
10.1176/APPI.PSY.43.4.259
Stress response syndromes and cancer: conceptual and assessment issues.
M. Gurevich (2002)
10.1093/annonc/mdw413
Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples.
L. Renfro (2017)
10.1093/ANNONC/MDH059
Modified RECIST criteria for assessment of response in malignant pleural mesothelioma.
M. Byrne (2004)
10.1093/jncimonographs/lgq002
The interface between primary and oncology specialty care: treatment through survivorship.
E. Grunfeld (2010)
10.1097/01.coc.0000190459.14841.55
Will Improvement in Quality of Life (QOL) Impact Fatigue in Patients Receiving Radiation Therapy for Advanced Cancer?
P. Brown (2006)
Psychological bases of perceived exertion
Borg GAV (1982)
10.1016/j.jtho.2017.02.026
Improved Outcomes with Modern Lung‐Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma
F. Shaikh (2017)
10.1177/000841743300100102
A Brief History of Occupational Therapy
W. J. Dunlop (1933)
cite a study published by The British Lung Foundation
Van Zandwijk (2013)
10.1046/J.1440-1630.2003.00323.X
A conceptual framework of functional capacity evaluation for occupational therapy in work rehabilitation
L. Gibson (2003)
10.1097/MCP.0b013e32833a897d
Role of pulmonary rehabilitation in the management of patients with lung cancer
V. Shannon (2010)
10.1016/S1470-2045(15)00007-8
Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy.
A. Sharabi (2015)
10.1016/j.cell.2017.05.016
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
R. Nusse (2017)
10.1177/019262339702500605
Growth Factor Responses and Protooncogene Expression of Murine Mesothelial Cell Lines Derived from Asbestos-Induced Mesotheliomas
L. Goodglick (1997)
10.4103/0973-1075.73670
Physical Therapy in Palliative Care: From Symptom Control to Quality of Life: A Critical Review
S. Kumar (2010)
10.3109/09540261.2013.864260
Prevalence, mechanisms, and management of cancer-related cognitive impairment
M. Janelsins (2014)
10.12968/IJPN.2003.9.4.11499
Non-pharmacological management of breathlessness: a collaborative nurse--physiotherapist approach.
Elaine Syrett (2003)
NCCN 2017a). Even though there is no known cure
Taioli (2015)
Under this model, practitioners give patients
Durand (2014)
10.1158/0008-5472.CAN-05-4668
A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent.
C. Robinson (2006)
「緩和ケア」として行われた介入と副次的評価項目であることの限界 (論文を読み,理解する--Early palliative care for patients with metastatic non-small-cell lung cancer)
森田 達也 (2011)
10.2522/ptj.20140106
Clinical Characteristics of Patients With Cancer Referred for Outpatient Physical Therapy
M. Alappattu (2014)
10.1080/03007995.2016.1226165
Symptom burden in mesothelioma patients admitted to home palliative care
S. Mercadante (2016)
10.1200/JGO.2017.010116
International Analysis of Age-Specific Mortality Rates From Mesothelioma on the Basis of the International Classification of Diseases, 10th Revision
P. Boffetta (2018)
By contrast, palliative care is designed for people with a serious progressive ill
hospices Gaertner (2011)
10.1136/EBN.9.2.44
Review: physical training increases cardiopulmonary fitness in asthma and does not decrease lung function
L. Cicutto (2006)
10.1186/s12885-015-1301-2
Epidemiological patterns of asbestos exposure and spatial clusters of incident cases of malignant mesothelioma from the Italian national registry
M. Corfiati (2015)
10.1016/j.lungcan.2013.09.016
Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma.
J. Creaney (2013)
10.1080/00049530903510757
Stress and depression of facing death: Investigation of psychological symptoms in patients with mesothelioma
J. Dooley (2010)
The functional independence measure: a new tool for rehabilitation.
R. Keith (1987)
10.1016/j.athoracsur.2014.09.056
Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma.
E. Taioli (2015)
10.1634/theoncologist.2016-0086
Thinking Systematically About the Off-Label Use of Cancer Drugs and Combinations for Patients Who Have Exhausted Proven Therapies
S. Mailankody (2016)
10.1158/1078-0432.CCR-17-1306
Dose-Finding Methods: Moving Away from the 3 + 3 to Include Richer Outcomes
X. Paoletti (2017)
Strong J. Occupational therapy and cancer rehabilitation
JC Wagner (2001)
Chemo-modulation of dendritic cells
thelioma Nowak (2003)
10.1007/978-3-319-53560-9_17
Challenges Facing Mesothelioma Patients and Their Families: Medical/Legal Intersections
Kirk Hartley (2017)
10.1016/j.ncl.2009.09.008
Neurotoxicity of radiation therapy.
E. Dropcho (2010)
10.1097/CEJ.0b013e3282f0c0a2
US mesothelioma patterns 1973–2002: indicators of change and insights into background rates
M. J. Teta (2008)
10.5694/mja12.11802
Asbestos exposure during home renovation in New South Wales
E. Park (2013)
10.1097/njh.0b013e31825e4250
Dyspnea Management in Early Stage Lung Cancer: A Palliative Perspective.
A. Williams (2012)
10.1001/JAMA.284.24.3187
Handbook for Mortals: Guidance for People Facing Serious Illness
T. Morris (2000)
10.1016/j.jtcvs.2014.10.041
Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experience.
L. Lang-Lazdunski (2015)
10.1186/s12885-016-2561-1
POSITIVE study: physical exercise program in non-operable lung cancer patients undergoing palliative treatment
J. Wiskemann (2016)
10.1080/14737140.2017.1358091
Immunotherapy advances for mesothelioma treatment
Emyr Bakker (2017)
10.1097/NJH.0000000000000187
Pulmonary Rehabilitation and Palliative Care for the Lung Cancer Patient
B. Tiep (2015)
10.5958/0973-5674.2016.00013.7
Immediate Effect of Pursed-lip Breathing while Walking During Six Minute Walk Test on Six Minute Walk Distance in Young Individuals
Shweta J Damle (2016)
published a landmark study of people with metastatic non-small
Temel (2010)
10.1002/1097-0142(19900915)66:6<1279::AID-CNCR2820660630>3.0.CO;2-R
A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer
E. Bruera (1990)
Most relevant to the mesothelioma population is the literature
Gaertner (2011)
10.1002/iid3.136
Transient Treg depletion enhances therapeutic anti‐cancer vaccination
Scott A Fisher (2017)
10.1200/JCO.2012.44.4661
Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer.
S. Yennurajalingam (2013)
10.1111/resp.12789
Immunotherapy for lung cancer
A. Steven (2016)
Otis-Green S, editors. Oxford textbook of palliative social work
T Altilio (2011)
10.1016/J.JTHO.2017.09.1326
P2.09-001 Effects of Tumor Burden Reduction on Survival in Epithelioid Pleural Mesothelioma
A. Mansfield (2017)
10.1016/j.ejon.2012.04.007
Understanding the meaning of fatigue at the end of life: an ethnoscience approach.
M. Kirshbaum (2013)
10.1186/s12885-015-1953-y
Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma
C. Robinson (2015)
10.1002/1097-0142(20010915)92:6+<1689::AID-CNCR1498>3.0.CO;2-H
Effects of exercise on cancer‐related fatigue
F. Dimeo (2001)
10.1097/NCC.0b013e3182759e21
Renegotiating Sex and Intimacy After Cancer: Resisting the Coital Imperative
J. Ussher (2013)
10.1586/14737140.2016.1162100
A catalogue of treatment and technologies for malignant pleural mesothelioma
Laurel M. Schunselaar (2016)
10.1007/978-3-642-41193-9_2
Occupational and Environmental Exposure to Asbestos
D. Darcey (2014)
10.6004/JNCCN.2013.0077
Double-crossed: why crossover in clinical trials may be distorting medical science.
V. Prasad (2013)
10.1016/j.chest.2016.10.007
Immunotherapy for Lung Malignancies: From Gene Sequencing to Novel Therapies
Jonathan D Chee (2017)
When anti-CTLA-4 ICPB antibody was added following radio
Wu (2015)
Additionally, mesothelioma disease-modifying therapies
Kao (2013)
10.1111/jocn.12584
Effects of an early postoperative walking exercise programme on health status in lung cancer patients recovering from lung lobectomy.
Naiwen Chang (2014)
10.1136/bmjopen-2015-010589
Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention
N. Bayman (2016)
10.1002/cncr.22830
Effects of presurgical exercise training on cardiorespiratory fitness among patients undergoing thoracic surgery for malignant lung lesions
L. Jones (2007)
Asbestos-related diseases of the lung.
Ullrich Ih (1980)
10.1093/ejcts/ezx079
Pleurectomy–decortication in malignant pleural mesothelioma: are different surgical techniques associated with different outcomes? Results from a multicentre study†
G. Marulli (2017)
10.1080/10962247.2016.1180329
Evaluation of asbestos-containing products and released fibers in home appliances
S. H. Hwang (2016)
10.1046/J.1533-2500.2001.01023-30.X
Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.
C. Cleeland (2000)
10.3109/0284186X.2012.725944
Opioids in pain management of mesothelioma and lung cancer patients
E. Salminen (2013)
10.21037/tlcr.2017.05.04
Intraoperative adjuncts for malignant pleural mesothelioma.
W. Chan (2017)
10.1080/23809000.2017.1345308
Mesothelioma survivorship: challenges in delivering quality care
G. Bates (2017)
The occupational therapist will also look to encourage discussions about spiritu
Sowden (2001)
10.1007/s00520-012-1569-6
Health-related quality of life and inflammatory markers in malignant pleural mesothelioma
S. Kao (2012)
10.1002/IJC.2910520609
Establishment of a murine model of malignant mesothelioma
M. R. Davis (1992)
10.1249/MSS.0000000000001082
Kinematic Mechanisms of How Power Training Improves Healthy Old Adults’ Gait Velocity
CHANTAL M. I. Beijersbergen (2017)
Effectiveness of megestrol acetate in patients with advanced cancer: a randomized, double-blind, crossover study.
E. Bruera (1998)
10.1007/s00520-017-3666-z
Physical function and health-related quality of life in patients undergoing surgical treatment for malignant pleural mesothelioma
T. Tanaka (2017)
10.1510/icvts.2008.181099
Incidence of atrial fibrillation after extrapleural pneumonectomy vs. pleurectomy in patients with malignant pleural mesothelioma.
S. Neragi-Miandoab (2008)
10.1172/JCI40269
Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice.
R. Ramakrishnan (2010)
10.1038/nature14292
Radiation and Dual Checkpoint Blockade Activates Non-Redundant Immune Mechanisms in Cancer
Christina Twyman-Saint Victor (2015)
10.1007/S11864-000-0047-4
Malignant pleural mesothelioma
H. Kindler (2000)
10.1016/j.lungcan.2017.01.004
Immune checkpoint inhibition in malignant mesothelioma: Does it have a future?
A. Mansfield (2017)
10.2105/AJPH.72.2.127
Education and counseling in hospital care.
J. Westermeyer (1982)
10.1007/s005200100252
Important drugs for cough in advanced cancer
J. Homsi (2001)
10.4414/pc-d.2007.07461
Palliative care.
Sean Morrison (1985)
10.1016/j.pmrj.2011.08.535
Radiation Fibrosis Syndrome: Neuromuscular and Musculoskeletal Complications in Cancer Survivors
M. Stubblefield (2011)
10.1200/JCO.2013.51.7540
Provision and discussion of survivorship care plans among cancer survivors: results of a nationally representative survey of oncologists and primary care physicians.
D. Blanch-Hartigan (2014)
10.1097/JOM.0000000000000235
Exploring the Usefulness of Occupational Exposure Registries for Surveillance
A. J. Koné Péfoyo (2014)
10.1007/s00520-011-1131-y
Standardizing integration of palliative care into comprehensive cancer therapy—a disease specific approach
J. Gaertner (2011)
10.1158/1078-0432.CCR-09-1961
Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee
S. Ivy (2010)
10.1200/JCO.2013.53.6680
Role of rehabilitation medicine and physical agents in the treatment of cancer-associated pain.
A. Cheville (2014)
10.1016/j.jtcvs.2015.09.129
Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma.
M. D. de Perrot (2016)
10.5114/aoms.2013.32806
Preoperative pulmonary rehabilitation in patients with non-small cell lung cancer and chronic obstructive pulmonary disease
N. Mujović (2014)
10.1097/JTO.0000000000000078
A Feasibility Study Evaluating Surgery for Mesothelioma After Radiation Therapy: The “SMART” Approach for Resectable Malignant Pleural Mesothelioma
B. Cho (2014)
10.1093/annonc/mdw405
Chromoplectic TPM3–ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib
A. Mansfield (2016)
10.2147/CIA.S59310
The effects of strength and power training on single-step balance recovery in older adults: a preliminary study
Derek N Pamukoff (2014)
10.1177/1352458511408475
Comparison of the 2- and 6-minute walk test in multiple sclerosis
D. Gijbels (2011)
10.1177/0004563217741145
Biomarkers in mesothelioma
D. Arnold (2018)
Occupational Therapy in Oncology and Palliative Care
J. Cooper (1997)
10.1089/jpm.2015.0351
The Growth of Palliative Care in U.S. Hospitals: A Status Report
Tamara Dumanovsky (2016)
10.1016/j.jtcvs.2007.10.054
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
R. Flores (2008)
A consensus seems to be emerging
Dumanovsky (2011)
10.1002/IJC.2910470219
Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions
L. S. Manning (1991)
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma
N van Zandwijk (2013)
10.1200/JCO.2003.11.136
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.
N. Vogelzang (2003)
10.1249/00005768-198205000-00012
Psychophysical bases of perceived exertion.
G. A. Borg (1982)
10.1111/j.1365-2354.2009.01162.x
Living with mesothelioma. A literature review
rn fetc consultant nurse L. Darlison bsc (2009)
10.1093/GERONA/59.7.M755
The deleterious effects of bed rest among community-living older persons.
T. Gill (2004)
10.1016/S0885-3924(98)00065-7
Dyspnea in the advanced cancer patient.
D. Dudgeon (1998)
10.12659/AJCR.894180
Primary Peritoneal Mesothelioma Resulting in Small Bowel Obstruction: A Case Report and Review of Literature
S. C. N. Frontario (2015)
10.1136/bmjspcare-2014-000649
How to communicate with patients about future illness progression and end of life: a systematic review
R. Parry (2014)
To measure how hard a patient is working to breath is determined by a scale
Tiep (2015)
10.1097/JTO.0b013e3181c5e366
Histone Deacetylase Inhibitors in Malignant Pleural Mesothelioma: Preclinical Rationale and Clinical Trials
P. Paik (2010)
10.1177/030802260707000705
The Importance of Job Analysis in Occupational Therapy
Malcolm Joss (2007)
10.1510/icvts.2010.264507
Is preoperative physiotherapy/pulmonary rehabilitation beneficial in lung resection patients?
K. Nagarajan (2011)
10.1172/JCI43656
Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice.
W. Lesterhuis (2011)
10.1016/S0140-6736(12)60776-4
Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial
N. Ryan (2012)
Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma.
T. Taguchi (1993)
10.1056/NEJMra1510062
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both.
J. Woodcock (2017)
10.1016/S1470-2045(11)70149-8
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
T. Treasure (2011)
10.1097/JTO.0b013e31826915f1
Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database
V. Rusch (2012)
10.1016/j.jpainsymman.2011.03.025
Identification of factors associated with fatigue in advanced cancer: a subset analysis of the European palliative care research collaborative computerized symptom assessment data set.
O. Minton (2012)
10.15761/MRI.1000110
Peritoneal mesothelioma in a young woman: Case report of radiopathologic findings and review of the literature
A. Ellenbogen (2017)
10.3322/caac.20093
Self‐management: Enabling and empowering patients living with cancer as a chronic illness
R. McCorkle (2011)
10.1001/jama.2012.29
Caregiving burden, stress, and health effects among family caregivers of adult cancer patients.
M. Bevans (2012)
10.5055/jom.2013.0168
Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases.
Helle Gamborg (2013)
10.1634/theoncologist.2010-0193
Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory.
T. Mendoza (2011)
10.1093/MED/9780199739110.001.0001
Oxford textbook of palliative social work
T. Altilio (2011)
10.1016/J.JSS.2012.10.834
An Oncolytic Vaccinia Virus Expressing the Human Sodium Iodine Symporter Prolongs Survival and Facilitates SPECT/CT Imaging in an Orthotopic Model of Malignant Pleural Mesothelioma
Laurence J. Belin (2013)
10.1097/JTO.0000000000000064
Does Surgery Improve Survival of Patients with Malignant Pleural Mesothelioma?: A Multicenter Retrospective Analysis of 1365 Consecutive Patients
P. Bovolato (2014)
10.1016/j.clgc.2013.07.003
The validity and utility of the MD Anderson Symptom Inventory in patients with prostate cancer: evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology Group.
D. Jones (2014)
10.3390/ijerph10115629
Domestic Asbestos Exposure: A Review of Epidemiologic and Exposure Data
E. Goswami (2013)
10.1016/j.jss.2015.01.043
Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database.
R. Meyerhoff (2015)
The authors suggest this could be the positive effects
D’Agostin (2017)
Great Britain in the 1960s, where she founded St. Christopher’s
Saunders (1960)
10.7326/0003-4819-132-5-200003070-00012
Responding to Intractable Terminal Suffering: The Role of Terminal Sedation and Voluntary Refusal of Food and Fluids
T. Quill (2000)
10.1158/1078-0432.CCR-09-1624
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
J. Wolchok (2009)
10.1001/jamaoncol.2016.5299
Novel Precision Medicine Trial Designs: Umbrellas and Baskets.
H. West (2017)
10.1016/S1053-4296(03)00037-7
Late radiation-related fibrosis: pathogenesis, manifestations, and current management.
B. O'Sullivan (2003)
2011,). Importantly, MexTAg mice
Robinson (2006)
10.1093/jnci/djq097
Impact of cultural and linguistic factors on symptom reporting by patients with cancer.
X. Wang (2010)
10.1158/1078-0432.CCR-17-0438
In Situ Vaccination after Accelerated Hypofractionated Radiation and Surgery in a Mesothelioma Mouse Model
L. M. de la Maza (2017)
10.1016/J.JTHO.2017.09.333
OA 02.07 Surgical Selection in Pleurectomy Decortication for Mesothelioma – an Overview from Screening and Selection from MARS 2 Pilot
M. Trialists (2017)
10.1080/2162402X.2015.1011492
Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen
J. Creaney (2015)
2017). As patients and families navigate the transition
families Shalev (2017)
10.1093/GERONJ/45.6.M192
Functional reach: a new clinical measure of balance.
P. Duncan (1990)
10.1093/annonc/mdn068
Effects of an endurance and resistance exercise program on persistent cancer-related fatigue after treatment.
F. Dimeo (2008)
10.1016/j.lungcan.2015.09.021
Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma.
L. Santarelli (2015)
10.1056/NEJMRA050152
Advances in malignant mesothelioma.
B. Robinson (2005)
10.21037/atm.2017.03.74
Environmental asbestos exposure and risk of mesothelioma.
C. Noonan (2017)
10.1016/j.cllc.2017.03.010
LUME-Meso: Design and Rationale of the Phase III Part of a Placebo-Controlled Study of Nintedanib and Pemetrexed/Cisplatin Followed by Maintenance Nintedanib in Patients With Unresectable Malignant Pleural Mesothelioma.
Giorgio V. Scagliotti (2017)
10.1038/nrclinonc.2014.127
Cancer-related fatigue—mechanisms, risk factors, and treatments
J. Bower (2014)
10.1136/oem.2009.051466
Incidence of extrapleural malignant mesothelioma and asbestos exposure, from the Italian national register
A. Marinaccio (2010)
Management of cough in advanced cancer.
B. Estfan (2004)
In this context we would like to strongly encourage patients
Rimner (2016)
The benefits of the subcutaneous model lie in the simplicity of the method
models Cleo Robinson (2014)
One review suggests that using the SDM model improves
McCorkle (2011)
The goal of this chapter is to cover what is known about how people respond to an upcoming death, the actual dying process, and after the death
Moore (2010)
10.2190/NS.21.4.j
Ban Asbestos Phenomenon: The Winds of Change
L. Kazan-Allen (2011)
10.1002/cpt.814
Critical Review of Umbrella, Basket, and Platform Designs for Oncology Clinical Trials
Richard B. Simón (2017)
10.1123/JAPA.17.4.416
Lower extremity muscle function after strength or power training in older adults.
A. Marsh (2009)
Guidelines for Pathologic Diagnosis of Malignant Mesothelioma
Aliya N. Husain (2017)
10.1186/2049-6958-5-3-202
Measures of dyspnea in pulmonary rehabilitation
E. Crisafulli (2010)
10.1093/annonc/mds539
The FACT-G7: a rapid version of the functional assessment of cancer therapy-general (FACT-G) for monitoring symptoms and concerns in oncology practice and research.
B. Yanez (2013)
10.2174/1389450116666150804110714
Molecular Pharmacology of Malignant Pleural Mesothelioma: Challenges and Perspectives From Preclinical and Clinical Studies.
S. Thellung (2016)
10.4103/0973-1075.53507
Fatigue in Cancer: A Review of Literature
V. Narayanan (2009)
10.1007/978-3-319-53560-9
Asbestos and Mesothelioma
J. Testa (2017)
10.1165/RCMB.2002-0226OC
Efficacy of CD40 ligand gene therapy in malignant mesothelioma.
P. Friedlander (2003)
10.4103/apjon.apjon_14_17
Hand-held Fan Airflow Stimulation Relieves Dyspnea in Lung Cancer Patients
Ni Luh Putu Dewi Puspawati (2017)
10.21037/atm.2017.03.88
A nuanced view of extrapleural pneumonectomy for malignant pleural mesothelioma.
I. Opitz (2017)
10.1097/00001622-200207000-00004
Dyspnea: the continuing challenge of palliative management
S. Legrand (2002)
In conditionally replicating adenoviruses, expression of viral protein
Friedlander (2003)
2016). Although little data supports drug therapies for CRF
Wiskemann (2016)
Pursed-lip breathing is a form of “breath training
Tiep (2015)
cite a study published by The British Lung Foundation
Van Zandwijk (2013)
10.1177/000313481508101228
Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma: Experience of a Peritoneal Surface Malignancy Center
N. Aydin (2015)
10.5694/mja11.10125
Increasing incidence of malignant mesothelioma after exposure to asbestos during home maintenance and renovation
Nola J. Olsen (2011)
10.1155/2011/745047
Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline.
D. Marciniuk (2011)
10.4049/jimmunol.171.10.5051
IL-2 Intratumoral Immunotherapy Enhances CD8+ T Cells That Mediate Destruction of Tumor Cells and Tumor-Associated Vasculature: A Novel Mechanism for IL-2 1
C. Jackaman (2003)



Semantic Scholar Logo Some data provided by SemanticScholar